HAG
HighPoint Advisor Group’s BioXcel Therapeutics BTAI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-12,185
| Closed | -$354K | – | 570 |
|
2021
Q2 | $354K | Sell |
12,185
-488
| -4% | -$14.2K | 0.04% | 367 |
|
2021
Q1 | $455K | Buy |
12,673
+334
| +3% | +$12K | 0.05% | 292 |
|
2020
Q4 | $737K | Sell |
12,339
-1,015
| -8% | -$60.6K | 0.09% | 183 |
|
2020
Q3 | $717K | Sell |
13,354
-4,851
| -27% | -$260K | 0.13% | 134 |
|
2020
Q2 | $974K | Buy |
18,205
+10,530
| +137% | +$563K | 0.21% | 92 |
|
2020
Q1 | $236K | Buy |
+7,675
| New | +$236K | 0.06% | 263 |
|